Autoimmune Encephalitis (AIE) Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Autoimmune Encephalitis (AIE) Treatment Market is segmented By Treatment (Immunotherapy (Monoclonal Antibodies, Checkpoint Inhibitors), Anti-inflammatory Drugs, Corticosteroids, Plasmapheresis, Intravenous Immunoglobulins (IVIG)), By Diagnosis (Magnetic Resonance Imaging (MRI), Electroencephalography (EEG), Cerebrospinal Fluid (CSF) Analysis, Antibody Testing), By End User (Hospitals, Clinics, Diagnostic Centers, Research Institutes), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.

Autoimmune Encephalitis (AIE) Treatment Market is segmented By Treatment (Immunotherapy (Monoclonal Antibodies, Checkpoint Inhibitors), Anti-inflammat....

Autoimmune Encephalitis (AIE) Treatment Market Size

Market Size in USD

CAGR9%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	9%
Market Concentration	Medium
Major Players	Roche Holding AG, Pfizer Inc., Novartis AG, Johnson & Johnson, Merck & Co., Inc.

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Autoimmune Encephalitis (AIE) Treatment Market Analysis

The autoimmune encephalitis (AIE) treatment market is estimated to be valued at USD 1.3 Billion in 2024 and is expected to reach USD 2.4 Billion by 2031, growing at a compound annual growth rate (CAGR) of 9% from 2024 to 2031. Factors such as rising incidences of autoimmune neurological disorders, increasing adoption of immune therapies, and growing awareness among patients about available treatments are expected to drive the autoimmune encephalitis (AIE) treatment market during the forecast period.

Autoimmune Encephalitis (AIE) Treatment Market Report Snapshots

Buy Now